期刊文献+

肝素诱导的血小板减少症1例

Heparin-induced thrombocytopenia in 1 case
下载PDF
导出
摘要 1病例资料,患者男,65岁,因发现“皮肤巩膜黄染20余日”于2022年10月9日收入山东大学齐鲁医院。入院后完善相关检查,初步诊断:(1)胆管占位,(2)梗阻性黄疸。于2022年10月21日在全身麻醉下行左半肝切除+左侧尾状叶切除(Ⅰ段)+肝门部胆管癌根治+腹腔区域淋巴结清扫术。术后病理示(肝门部胆管)高-中分化腺癌。术后患者恢复可。病情平稳后,于术后第17天常规使用低分子肝素抗凝。监测相关血液指标,发现血小板进行性下降,表现为术后第17天血小板计数为107×10^(9)/L,术后第23天为63×10^(9)/L,术后第24天为43×10^(9)/L,术后第26天为31×10^(9)/L。请血液科会诊,考虑为肝素诱导的血小板减少症(heparin-induced thrombocytopenia,HIT),建议停用低分子肝素。停用后监测血小板变化,给予对症及支持治疗,定期复查血常规、血生化、肝功等相关指标。术后第28天血小板计数为21×10^(9)/L,术后第29天为19×10^(9)/L,术后第30天为20×10^(9)/L,术后第32天为44×10^(9)/L,术后第33天为56×10^(9)/L,术后第35天为85×10^(9)/L,术后第37天为126×10^(9)/L,血小板数量逐渐上升,恢复到正常范围内,于2022年11月26日出院。
作者 单勇 孙栋 郭森 SHAN Yong;SUN Dong;GUO Sen
出处 《中国现代普通外科进展》 CAS 2023年第8期661-662,共2页 Chinese Journal of Current Advances in General Surgery
  • 相关文献

参考文献5

二级参考文献71

  • 1Warkentin TE.An overview of the heparin-induced thrombocytopenia syndrome[J],Semin Thromb Hemost, 2004 : 30: 273- 283.
  • 2Massimo Franchini.Heparin-induced thrombocytopenia:a update[J].Thromb J ,2005,3 : 14.
  • 3Alberio, Lorenzo.Heparin -induced thrombocytopenia: some working hypotheses on pathogenesis,diagnostic strategies and treatment [J].Hemostasis and thrombosis,2008,15 (5):456- 464.
  • 4Kelton JG,Smith JW,Warkentin TE,et al.Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4 [J].Blood, 1994,83 : 3232-3239.
  • 5Visentin GP,Ford SE,Scott JP,et al.Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor g complexed with heparin or bound to endothelial cells[J].J Clin Invest,1994,93:81-88.
  • 6Kannan,Meganathana,Ahmad,et al.Functional characterization of antibodies against heparin-platelet factor 4 complex in heparin-induced thrombocytopenia patients in Asian-Indians:relevance to inflammatory markers [J].Blood Coagulation & Fibrinolysis,2008,19(6) :471-475.
  • 7Warkentin TE,Kelton JG.Temporal aspects of heparin-induced thrombocytopenia [J].N Engl J Med,2001,394:1286- 1292.
  • 8Andresscu AC,Possidente C,Hsieh M,et al.Evaluation of a pharmacy-based surveillance program for hepafin-induced thrombocytopenia[J].Pharmacotherapy, 2002,20: 974-980.
  • 9Warkentin TE,Sheppard JI,Horsewood P,et al.lmpact of the patient population on the risk for heparin-induced thrombocytopenia[J].Blood , 2000,96:1703-1708.
  • 10Warkentin TE,Greinacher A.Heparin-induced thrombocytopenia:recognition,treatment and prevention:the seventh ACCP conference on antithrombotic and thrombolytic therapy[J].Chest, 2004,126 : 311-337.

共引文献181

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部